Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
¶ … U.S. Healthcare
Hard Economic and Finance Choices in U.S. Healthcare
The United States has recently undergone a financial crisis that has made the government, and the citizens, more conscious of what things cost and have produced debates regarding the costs of items. One debate that has intensified in volume is that over the large, and ballooning cost of healthcare. Although the Affordable Healthcare Act is supposed to take care of a portion of that, evidence shows that costs will remain exorbitant. The main reason for that is the research and development costs of therapies and associated drug treatments. Currently, new therapies have been coming on the market that are able to prolong the lives of cancer patients, but a cost-benefit analysis prove that these therapies are too costly. The debate then is whether a few weeks, months, years of life are worth hundreds of thousands to millions of dollars. This paper looks at some recent examples of cost and treatment application to determine whether there is a better way to manage overall treatment (i.e., healthcare for the entire U.S.) that will also be cost effective.
The first question many in this debate ask is what is the value of one human life? Given that there are approximately 320 million people currently living in the United States, is it worthwhile to spend hundreds of thousands to extend the life of one. The reason for the question is that if that large amount of money were not used for the one patient, it could be used for treatments for many other deserving people (Stein, 2010). The individual human side of the debate asks what an individual would give to prolong their own...
Popularly called Obamacare, the Act has one provision for a select committee that oversees what will and will not be paid for by Medicare. The issue here is that a sweeping declaration, such as discontinuing the approval for Provenge as a treatment for late stage prostate cancer, can cause serious harm to a lot of people. The committee does not, by law, take cost of treatment into account, but it is difficult to believe this statement when the drug mentioned above costs $93,000 per treatment and only extends the patient's life by an average of 4 months (Stein, 2010). To the majority of people this may sound extreme, but to those who have the disease and want to live a few extra months to be with family a little longer, it does not seem like a large expense at all (Stein, 2010).
Short (2013) makes the statement that economics is amoral and that "the health market as viewed by economists is amoral: when confronted by finite resources there will be winners and losers." These are all true statements. Economics, by definition does not look at the right or wrong of a decision, but in the economics behind it. As Short (2013) suggests, morality is left to politicians and others. However, even if the actual numbers are amoral, the decisions about what to do with those…
References
Short, N.M. (2013). Overview: The Economics and Finance of Health Care. In J.A. Milstead (Ed.), Health policy and politics: A nurse's guide (4th ed.) (pp. 191 -- 206). Sudbury, MA: Jones and Bartlett Publishers.
Stein, R. (2010, November 8). Review of prostate cancer drugs Provenge renews medical cost-benefit debate. The Washington Post. Retrieved from http://www.washingtonpost.com/wp- dyn/content/article/2010/11/07/AR2010110705205.html ?
Sullivan, J.D. (2010). End Stage Renal Disease economics and the balance of treatment modalities. Journal of Service Science & Management, 3(1), 45 -- 50. Retrieved from the Walden Library databases.
Health Care in the U.S. And Spain What Can the U.S. Learn About Health Care from Spain? In 2009, Spain's single-payer health care system was ranked the seventh best in the world by the World Health Organization (Socolovsky, 2009). By comparison, the U.S. health care system ranted at 37 (Satiroglou, 2009). The Spanish system offers coverage as a right of citizenship that is constitutionally guaranteed. Spanish residents pay no expenses out-of-pocket, with
"Studies of the relationship between managed care penetration in the health care market and expenditures for Medicare fee-for-service enrollees have demonstrated the existence of these types of spill over effects" (Bundorf et al., 2004). Managed care organizations generate these types of spillover effects by increasing competition in the health care market, altering the arrangement of the health care delivery system, and altering physician practice patterns. Studies have found that higher
Healthcare Information Technology Electronic Medical Record: User friendliness is among the significant factors- probably the most essential factor- hampering extensive usage of Electronic Medical Record EMRs in respiratory therapy within my organization. User friendliness features a powerful, usually direct connection with my organization's efficiency, error level, operator exhaustion and operator satisfaction- are all essential elements for EMR usage. Moreover, within my organization, it's been observed that efficient coaching and execution techniques impact
Affordable Health Care Act Impact of the affordable health care act The affordable health care act, commonly referred to as Obamacare, brought a set of health care reforms aimed at making health consumers to be responsible for their health care. The act brought into law the patient's bill of rights, which gives Americans stability and flexibility in making informed health choices and decisions. Enacted by President Obama in 2010 as the Affordable
The Foundation called specific attention to the prospect of institutional and policy-level strategies to increase the participation of under-represented minorities in the health professions. In response, the Institute Committee on Institutional and Policy-Level Strategies for Increasing the Diversity of the U.S. Healthcare Workforce came out with a report, entitled "In the Nation's Compelling Interest: Ensuring Diversity in the Health Care Workforce." The Committee consisted mostly of academicians, two of
Role that competition plays in U.S. healthcare This paper presents a detailed examination of the role that competition plays in U.S. healthcare. The writer explores the impact that the ability to compete for consumers has on the health care industry in America. The writer also looks at the behavior of private and public organizations throughout the nation in the health care industry and speculates both negative and positive conclusions about the